Cancer guide
By Cura Editorial Team ·
Most kidney cancers are found by accident on a scan done for something else — and small tumors have excellent outcomes with surgery or ablation.
Recent approvals and trial results — and the questions to ask your oncologist about whether any of it applies to you. Not every option fits every person.
The FDA approved belzutifan with pembrolizumab after surgery for high-risk kidney cancer after the LITESPARK-022 trial showed a 28% lower risk of recurrence or death.
May apply to: Clear cell kidney cancer at high risk after surgery
Ask your oncologist:
Source: FDA
The FDA approved belzutifan with lenvatinib for advanced clear cell kidney cancer after immunotherapy.
May apply to: Advanced clear cell kidney cancer after immunotherapy
Ask your oncologist:
Source: The Pharma Letter
Reviewed September 25, 2026.
Email me when something new is approved for kidney cancer
Only real treatment news for this cancer, in plain language. Optional — the guide and Ask Cura stay free and anonymous. Unsubscribe anytime.
The signs that most often lead to a kidney cancer diagnosis are: blood in the urine, even once; persistent flank or back pain on one side; an unexplained mass, fatigue, or weight loss. Any of these lasting more than a couple of weeks is worth a same-week appointment, even though most turn out to be something else.
See a doctor promptly if a symptom is new, persistent, or getting worse rather than better. Describe when it started, how often it happens, and what makes it better or worse — that detail is what decides whether you get imaging or testing at the first visit.
Most kidney cancers are found by accident on a scan done for something else — and small tumors have excellent outcomes with surgery or ablation. The most common type is renal cell carcinoma (RCC), often clear cell. Small (<4 cm) tumors are often treated with partial nephrectomy or ablation, not full kidney removal. Immunotherapy combinations have changed the outlook for advanced disease.
Ask what the exact diagnosis is and how it is staged, what the treatment options are and in what order they would happen, what the goal of treatment is, which side effects to expect, and whether a second opinion or clinical trial makes sense for your situation.
Paste a pathology report, upload a scan summary, or just type the question you'd ask your oncologist if you had more than 15 minutes. Cura will answer in plain language.
Ask CuraWant occasional plain-language health explainers?
A short note now and then. No spam, unsubscribe anytime.
If a start date is on the calendar, or you feel lost between diagnosis and the first infusion, build a first-visit brief on the page: what's known, what's missing, what to ask. Homework, not a treatment plan.
Cura Brief is educational. It is not medical advice, a diagnosis, or a treatment plan. Confirm everything with your oncology team. If this is an emergency, call emergency services. Email is not an emergency line.
Prefer email? hello@curawellplan.com
Waiting for results is its own kind of hard. Cura has a plain-language guide to what the wait actually means — and what to do while you wait.
How long do biopsy results take?